Big Pharma paying off generic drug manufacturers to avoid competition

A report by the Federal Trade Commission has found that Big Pharma is paying off generic drug manufacturers in order to sell brand-name products for longer periods without competition.

Apparently, the generic drug manufacturers can make more money from witholding their drugs from the market than from selling them.

Leave a comment